semaglutide andrew huberman Neuroscientist Dr discusses the potential use of low-dose GLP-1 receptor agonists for cognitive well-being and neuroprotection. >> See comments 👇 The trillion-dollar peptide. Appearing on

Just clear guidance and care designed to support your progress.

Spade RX, PC does not prescribe, dispense, distribute, or facilitate the prescribing of controlled substances

This is actually unusual in the compounded GLP-1 space, where most providers increase pricing as doses escalate because higher doses require more active ingredient per vial

Customers who set realistic goals and stick with a 3-6 month supply report the strongest satisfaction

They should seek medical advice if such adverse effects are severe, or occur for an extended period, so that their provider may consider dose adjustment (when applicable), discontinuation, or alternative therapies (63)

Evidence from the same research field indicates that GLP-1 medications, particularly semaglutide, have shown an impact on addiction and substance use disorders